Caffeic acid phenethyl ester inhibits nuclear factor-kappaB and protein kinase B signalling pathways and induces caspase-3 expression in primary human CD4+ T cells

Clin Exp Immunol. 2010 May;160(2):223-32. doi: 10.1111/j.1365-2249.2009.04067.x. Epub 2010 Jan 6.

Abstract

Caffeic acid phenethyl ester (CAPE), an active component in propolis, is known to have anti-tumour, anti-inflammatory and anti-oxidant properties. In this study, the effects of CAPE on the functions of primary human CD4+ T cells were evaluated in vitro. CAPE significantly suppressed interferon (IFN)-gamma and interleukin (IL)-5 production and proliferation of CD4+ T cells stimulated by soluble anti-CD3 and anti-CD28 monoclonal antibodies in both healthy subjects and asthmatic patients. CAPE inhibited nuclear factor (NF)-kappaB activation and protein kinase B (Akt) phosphorylation, but not p38 mitogen-activated protein kinase (MAPK) phosphorylation in T cells. CAPE also induced active caspase-3 expression in CD4+ T cells; CCR4+CD4+ T cells were more sensitive to CAPE induction than CXCR3+CD4+ T cells. Together, these results indicate that CAPE inhibits cytokine production and proliferation of T cells, which might be related to the NF-kappaB and Akt signalling pathways, and that CCR4+CD4+ T cells are more sensitive to CAPE inhibition. This study provides a new insight into the mechanisms of CAPE for immune regulation and a rationale for the use of propolis for the treatment of allergic disorders.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antigens, Dermatophagoides / adverse effects
  • Antigens, Dermatophagoides / immunology
  • Asthma / etiology
  • Asthma / immunology*
  • Asthma / pathology
  • CD4-Positive T-Lymphocytes / chemistry
  • CD4-Positive T-Lymphocytes / drug effects*
  • CD4-Positive T-Lymphocytes / enzymology
  • CD4-Positive T-Lymphocytes / metabolism
  • Caffeic Acids / pharmacology*
  • Caspase 3 / biosynthesis*
  • Caspase 3 / genetics
  • Cells, Cultured / drug effects
  • Cytokines / metabolism
  • Drug Evaluation, Preclinical
  • Enzyme Activation / drug effects
  • Enzyme Induction / drug effects
  • Humans
  • Lymphocyte Activation / drug effects
  • NF-kappa B / antagonists & inhibitors*
  • Phenylethyl Alcohol / analogs & derivatives*
  • Phenylethyl Alcohol / pharmacology
  • Phosphorylation / drug effects
  • Propolis / chemistry
  • Protein Processing, Post-Translational / drug effects
  • Proto-Oncogene Proteins c-akt / antagonists & inhibitors*
  • Receptors, CCR4 / analysis
  • Receptors, CXCR3 / analysis
  • Signal Transduction / drug effects*
  • T-Lymphocyte Subsets / chemistry
  • T-Lymphocyte Subsets / drug effects*
  • T-Lymphocyte Subsets / enzymology
  • T-Lymphocyte Subsets / metabolism
  • p38 Mitogen-Activated Protein Kinases / metabolism

Substances

  • Antigens, Dermatophagoides
  • CCR4 protein, human
  • CXCR3 protein, human
  • Caffeic Acids
  • Cytokines
  • NF-kappa B
  • Receptors, CCR4
  • Receptors, CXCR3
  • Propolis
  • Proto-Oncogene Proteins c-akt
  • p38 Mitogen-Activated Protein Kinases
  • Caspase 3
  • caffeic acid phenethyl ester
  • Phenylethyl Alcohol